Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 4 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | — 6,349 sh |
| Apr 15, 2026 traded Apr 13, 2026 |
| 4 | Hoffmann MartinCEO | Open-market sale · 10b5-1 plan | SELL | $141K 4,150 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 4 | Mat IshbiaDirector, President and CEO, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 11.00M sh | Apr 15, 2026 traded Apr 15, 2026 |
| 4 | Slessor MikeDirector, CEO | Open-market sale · 10b5-1 plan | SELL | $99K 767 sh | Apr 15, 2026 traded Apr 15, 2026 |
| 4 | Slessor MikeDirector, CEO | Open-market sale · 10b5-1 plan | SELL | $229K 1,826 sh | Apr 15, 2026 traded Apr 15, 2026 |
| 4 | Mater Tonya L.SVP & Chief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $147K 2,600 sh | Apr 15, 2026 traded Apr 15, 2026 |
| 3 | Craig Jonathan M.MD, Head of Retail Investing | Option exercise · 10b5-1 plan | M | — 21.8K sh | Apr 15, 2026 traded Apr 14, 2026 |
| 2 | Prober Charles J.Director | Option exercise · 10b5-1 plan | M | $89K 7,930 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 1 | Susi Roger E.Director, CEO, President, Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $170K 1,847 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 1 | Susi Roger E.Director, CEO, President, Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $55K 589 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 1 | Susi Roger E.Director, CEO, President, Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $197K 2,107 sh | Apr 15, 2026 traded Apr 14, 2026 |
| 1 | Susi Roger E.Director, CEO, President, Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $238K 2,564 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | Inrig JulaCHIEF MEDICAL OFFICER | Grant or award · 10b5-1 plan | A | — 14.0K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | $59K 4,167 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 16.7K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | Susi Roger E.Director, CEO, President, Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $37K 393 sh | Apr 15, 2026 traded Apr 14, 2026 |
| 0 | Spector DavidDirector, Chairman & CEO | Open-market sale · 10b5-1 plan | SELL | $39K 417 sh | Apr 15, 2026 traded Apr 14, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | Derivative conversion · 10b5-1 plan | C | — 900.0K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 100.0K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | Yuan Eric S.Director, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 69.9K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | Derivative conversion · 10b5-1 plan | C | — 225.0K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 6,250 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | Murtagh Nigel JChief Risk Officer | Option exercise · 10b5-1 plan | M | — 41.3K sh | Apr 15, 2026 traded Apr 14, 2026 |
| 0 | Yuan Eric S.Director, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 15.3K sh | Apr 15, 2026 traded Apr 14, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | $36K 3,542 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | $6,857 6,349 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | Yuan Eric S.Director, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 15.3K sh | Apr 15, 2026 traded Apr 14, 2026 |
| 0 | Rote William E.Chief Research Officer | Grant or award · 10b5-1 plan | A | — 14.0K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | Siebel Thomas MDirector, Executive Chairman, 10% Owner | Option exercise · 10b5-1 plan | M | — 165.3K sh | Apr 15, 2026 traded Apr 14, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | — 4,167 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 16.7K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | Kutua LubiCFO, Treasurer | Tax withholding · 10b5-1 plan | F | $797 1,208 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | Derivative conversion · 10b5-1 plan | C | — 900.0K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | Derivative conversion · 10b5-1 plan | C | — 225.0K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | Prober Charles J.Director | Option exercise · 10b5-1 plan | M | — 7,930 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | Mat IshbiaDirector, President and CEO, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 11.00M sh | Apr 15, 2026 traded Apr 15, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 16.7K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 6,250 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | Dube Eric MDirector, CHIEF EXECUTIVE OFFICER | Grant or award · 10b5-1 plan | A | — 64.0K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 100.0K sh | Apr 15, 2026 traded Apr 13, 2026 |